202
Participants
Start Date
September 26, 2016
Primary Completion Date
December 11, 2017
Study Completion Date
February 6, 2020
Atezolizumab
Atezolizumab 1200 mg IV infusion
Trastuzumab emtansine
Trastuzumab emtansine 3.6 mg/kg IV infusion
Placebo
Placebo matched to atezolizumab
National Taiwan Uni Hospital; General Surgery, Taipei
Chang Gung Memorial Hospital - Linkou, Taoyuan District
China Medical University Hospital; Surgery, Taichung
Changhua Christian Hospital; Dept of Surgery, Changhua
Chi-Mei Medical Center, Tainan City
Kaohsiung Medical Uni Chung-Ho Hospital; Dept of Surgery, Kaohsiung City
St George Hospital; Cancer Care Centre, Kogarah
Calvary Mater Newcastle, Waratah
Peter MacCallum Cancer Center, East Melbourne
Sunshine Hospital, St Albans
Peninsula and South Eastern Haematology and Oncology Group, Frankston
Princess Alexandra Hospital Woolloongabba; Clinical Hematology and Medical Oncology, Woolloongabba
St John of God Hospital; Bendat Cancer Centre, Subiaco
Laura and ISAAC Perlmutter Cancer Center at NYU Langone., New York
National Cancer Center, Goyang-si
Koo Foundation Sun Yat-Sen Cancer Center; Hemato-Oncology, Taipei
HELIOS Klinikum Berlin-Buch; Klinik für Gynäkologie und Geburtshilfe, Berlin
Hospital Universitario Reina Sofia; Servicio de Oncologia, Córdoba
Studienzentrum Berlin City, Berlin
Complejo Hospitalario Universitario A Coruña (CHUAC, Materno Infantil), Oncología, A Coruña
Magee Womens Hospital, Pittsburgh
Cancer Care Associates of York, York
MedStar Georgetown University Hospital (Lombardi Comprehensive Cancer Center), Washington D.C.
Johns Hopkins Univ Med Center, Baltimore
Hospital Ramon y Cajal; Servicio de Oncologia, Madrid
Northside Hospital, Atlanta
Centro Di Riferimento Oncologico; SOC Oncologia Medica C, Aviano
Florida Cancer Specialists; Saint Petersburg, St. Petersburg
SCRI Florida Cancer Specialists South, Fort Myers
Tennessee Oncology; Sarah Cannon Research Institute, Nashville
SCRI Tennessee Oncology Chattanooga, Chattanooga
A.O.U Policlinico S. Orsola Malpighi di Bologna U.O di Medicina Interna Borghi - Pad.2, Bologna
Ospedale Regionale Di Parma; Divisione Di Oncologia Medica, Parma
Ohio State Uni Medical Center, Columbus
Klinikum Essen-Mitte Ev. Huyssens-Stiftung / Knappschafts GmbH; Klinik für Senologie / Brustzentrum, Essen
Hospital Clinico Universitario de Valencia; Servicio de Onco-hematologia, Valencia
Hospital Arnau de Vilanova (Valencia) Servicio de Oncologia, Valencia
Institut für Versorgungsforschung in der Onkologie GbR Koblenz, Koblenz
Ospedale Santo Stefano, Azienda USL Centro Prato, Prato
Nationales Centrum für Tumorerkrankungen (NCT) ; Gyn. Onk. Frauenklinik; Uniklinikum Heidelberg, Heidelberg
Praxis für Interdisziplinäre Onkologie und Hämatologie GbR, Freiburg im Breisgau
University of Colorado, Aurora
IRCCS Istituto Nazionale Tumori Fondazione Pascale; Oncologia Medica A, Napoli
San Juan Oncology Associates, Farmington
Breastlink Med Group Inc, Orange
Centro Catanese Di Oncologia; Oncologia Medica, Catania
University of Washington, Seattle
Lakeridge Health Oshawa; Oncology, Oshawa
The Ottawa Hospital Cancer Centre; Oncology, Ottawa
Sunnybrook Odette Cancer Centre, Toronto
McGill University; Sir Mortimer B Davis Jewish General Hospital; Oncology, Montreal
McGill University; Glen Site; Oncology, Montreal
Hopital du Saint Sacrement, Québec
Samsung Medical Center, Seoul
Seoul National University Hospital, Seoul
Severance Hospital, Yonsei University Health System, Seoul
Asan Medical Center, Seoul
Hospital Univ Vall d'Hebron; Servicio de Oncologia, Barcelona
VETERANS GENERAL HOSPITAL; Department of General Surgery, Taipei
Royal United Hospital; Oncology Department, Bath
Beatson West of Scotland Cancer Centre, Glasgow
Royal Free Hospital; Dept of Oncology, London
Royal Marsden Hosp NHS Fnd; Breast Unit, London
Christie Hospital; Breast Cancer Research Office, Manchester
Nottingham City Hospital, Nottingham
Weston Park Hospital; Cancer Clinical Trials Centre, Sheffield
Royal Marsden Hosp NHS Fnd; Medicine - Breast Unit, Sutton
Singleton Hospital; Pharmacy, Swansea
Hoffmann-La Roche
INDUSTRY